MedTrace Logo

Fertility in Healthy Premenopausal Women

NCT02772848 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-08-10

No results posted yet for this study

Summary

The study objectives are described below:

1. Obtain serum specimens collected for one ovulatory cycle or a maximum of 33 days, but not to exceed a total of 550 ml of whole blood per subject from a minimum of 60 healthy, premenopausal subjects. Specimens will be used to determine a reference range for estradiol, FSH, LH, and progesterone assays, used as an aid in the assessment of fertility in adult, premenopausal women.
2. To store any remaining specimens for use in future assay development and to evaluate as yet undetermined assays for the development of IVDs, including additional estradiol, FSH, LH, and progesterone assays.

Conditions

Sponsors & Collaborators

  • Fujirebio Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Diana Dickson · Fujirebio Diagnostics, Inc.

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02772848 on ClinicalTrials.gov